Zenas BioPharma, Inc. Common Stock Cash Flow Quality Index
Zenas BioPharma, Inc. Common Stock cash flow quality index. Zenas BioPharma, Inc. Common Stock (ZBIO) has a Cash Flow Quality Index of 0.89x as of September 2023. Operating cash flow of $31.85 Million is below net income of $35.61 Million, suggesting accrual-heavy earnings not yet converted to cash. See Zenas BioPharma, Inc. Common Stock financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zenas BioPharma, Inc. Common Stock Cash Flow Quality Index by Year (None–None)
Zenas BioPharma, Inc. Common Stock cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Zenas BioPharma, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Zenas BioPharma, Inc. Common Stock.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|